NFKB1 and COVID-19: Severe COVID-19 is linked to hyperactivation of NF-κB signaling, which causes the increased release of proinflammatory molecules such as IL-1, IL-6, IL-12, IL-17, IFN-γ or TNF-α by infiltrating immune cells [254,256,258].